Effects of type 2 diabetes and insulin on whole-body, splanchnic, and leg protein metabolism

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 12, 2012, Pages 4733-4741

  Short, Kevin R ^a,b   Irving, Brian A ^a   Basu, Ananda ^a   Johnson, C Michael ^a   Nair, K Sreekumaran ^a   Basu, Rita ^a  

^a MAYO CLINIC   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; PHENYLALANINE; TYROSINE;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN INFUSION; INSULIN SENSITIVITY; LEG PROTEIN METABOLISM; MALE; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN METABOLISM; PROTEIN SYNTHESIS; SPLANCHNIC PROTEIN METABOLISM; WHOLE BODY PROTEIN METABOLISM;

EID: 84870940825     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-2533     Document Type: Article

References (40)

1. Asmann YW, Stump CS, Short KR, Coenen-Schimke JM, Guo Z, Bigelow ML, Nair KS 2006 Skeletal muscle mitochondrial functions, mitochondrial DNA copy numbers, and gene transcript profiles in type 2 diabetic and non-diabetic subjects at equal levels of low or high insulin and euglycemia. Diabetes 55:3309-3319 (Pubitemid 44923587)
2. Bassil M, Marliss EB, Morais JA, Pereira S, Chevalier S, Gougeon R 2011 Postprandial hyperaminoacidaemia overcomes insulin resistance of protein anabolism inmenwith type 2 diabetes. Diabetologia 54:648-656
3. Basu A, Basu R, Shah P, Vella A, Johnson CM, Jensen M, Nair KS, Schwenk WF, Rizza RA 2001 Type 2 diabetes impairs splanchnic uptake of glucose but does not alter intestinal glucose absorption during enteral glucose feeding: additional evidence for a defect in hepatic glucokinase activity. Diabetes 50:1351-1362 (Pubitemid 32500168)
4. Basu A, Basu R, Shah P, Vella A, Johnson CM, Nair KS, Jensen MD, Schwenk WF, Rizza RA 2000 Effects of type 2 diabetes on the ability of insulin and glucose to regulate splanchnic and muscle glucose metabolism: evidence for a defect in haptic glucokinase activity. Diabetes 49:272-283 (Pubitemid 30071006)
5. Basu R, Basu A, Johnson CM, Schwenk WF, Rizza RA 2004 Insulin dose-response curves for stimulation of splanchnic glucose uptake and suppression of endogenous glucose production differ in nondiabetic humans and are abnormal in people with type 2 diabetes. Diabetes 53:2042-2050 (Pubitemid 38970753)
6. Bell JA, Volpi E, Fujita S, Cadenas JG, Sheffield-Moore M, Rasmussen BB 2006 Skeletal muscle protein anabolic response to increased energy and insulin is preserved in poorly controlled type 2 diabetes. J Nutr 136:1249-1255
7. Biolo G, Tessari P, Inchiostro S, Bruttomesso D, Sabadin L, Fongher C, Panebianco G, Fratton MG, Tiengo A 1992 Fasting and postmeal phenylalanine metabolism in mild type 2 diabetes. Am J Physiol 263:E877-E883
8. Boirie Y, Short KR, Ahlman B, Charlton M, Nair KS 2001 Tissue-specific regulation of mitochondrial and sarcoplasmic protein synthesis rates by insulin. Diabetes 50:2652-2658 (Pubitemid 33733114)
9. Charlton MR, Adey DB, Nair KS 1996 Evidence for a catabolic role of glucagon during an amino acid load. J Clin Invest 98:90-99 (Pubitemid 26243824)
10. Chow LS, Albright RC, Bigelow ML, Toffolo G, Cobelli C, Nair KS 2006 Mechanism of insulin's anabolic effect on muscle: measurements of muscle protein synthesis and breakdown using aminoacyl-tRNA and other surrogate measures. Am J Physiol Endocrinol Metab 291:E729-E736 (Pubitemid 44484914)
11. Denne SC, Brechtel G, Johnson A, Liechty EA, Baron AD 1995 Skeletal muscle proteolysis is reduced in non-insulin dependent diabetes mellitus and is unaltered by euglycemic hyperinsulinemia or intensive insulin therapy. J Clin Endocrinol Metab 80:2371-2377
12. Fujita S, Rasmussen BB, Cadenas JG, Grady JJ, Volpi E 2006 Effect of insulin on human skeletal muscle protein synthesis is modulated by insulin-induced changes in muscle blood flow and amino acid availability. Am J Physiol Endocrinol Metab 291:E745-E754 (Pubitemid 44484916)
13. Gelfand RA, Barrett EJ 1987 Effect of physiologic hyperinsulinemia on skeletal muscle protein synthesis and breakdown in man. J Clin Invest 80:1-6 (Pubitemid 17097508)
14. Gougeon R, Marliss EB, Jones PJH, Pencharz PB, Morais JA 1998 Effect of exogenous insulin on protein metabolism with differing nonprotein energy intakes in type 2 diabetes mellitus. Int J Obes 22:250-261 (Pubitemid 28112026)
15. Gougeon R, Morais JA, Chevalier S, Pereira S, Lamarche M, Marliss EB 2008 Determinants of whole-body protein metabolism in subjects with and without type 2 diabetes. Diabetes Care 31:128-133
16. Gougeon R, Pencharz PB, Marliss EB 1994 Effect of NIDDM on the kinetics of whole-body protein metabolism. Diabetes 43:318-328 (Pubitemid 24033688)
17. Gougeon R, Pencharz PB, Sigal RJ 1997 Effect of glycemic control on the kinetics of whole-body protein metabolism in obese subjects with non-insulin-dependent diabetes mellitus during iso- and hypoenergetic feeding. Am J Clin Nutr 65:861-870 (Pubitemid 27111097)
18. Halvatsiotis P, Short KR, Bigelow M, Nair KS 2002 Synthesis rates of muscle proteins, muscle functions, and amino acid kinetics in type 2 diabetes. Diabetes 51:2395-2404 (Pubitemid 34827387)
19. Halvatsiotis PG, Turk D, Alzaid A, Dinneen S, Rizza RA, Nair KS 2002 Insulin effect on leucine kinetics in type 2 diabetes mellitus. Diabetes Nutr Metab 15:136-142 (Pubitemid 34823241)
20. Laakso M, Edelman SV, Brechtel G, Baron AD 1992 Impaired insulin-mediated skeletal-muscle blood-flow in patients with NIDDM. Diabetes 41:1076-1083
21. Luzi L, Petrides AS, De Fronzo RA 1993 Different sensitivity of glucose and amino acid metabolism to insulin in NIDDM. Diabetes 42:1868-1877 (Pubitemid 23346425)
22. Manders RJ, Koopman R, Beelen M, Gijsen AP, Wodzig WK, Saris WH, van Loon LJ 2008 The muscle protein synthetic response to carbohydrate and protein ingestion is not impaired in men with longstanding type 2 diabetes. J Nutr 138:1079-1085 (Pubitemid 351769132)
23. Meek SE, Persson M, Ford GC, Nair KS 1998 Differential regulation of amino acid exchange and protein dynamics across splanchnic and skeletal muscle beds by insulin in healthy human subjects. Diabetes 47:1824-1835 (Pubitemid 28549187)
24. Moller N, Jensen MD, Rizza RA, Andrews JC, Nair KS 2006 Renal amino acid, fat and glucose metabolism in type 1 diabetic and nondiabetic humans: effects of acute insulin withdrawal. Diabetologia 49:1901-1908 (Pubitemid 44025045)
25. Møller N, Meek S, Bigelow M, Andrews J, Nair KS 2000 The kidney is an important site for in vivo phenylalanine-to-tyrosine conversion in adult humans: a metabolic role of the kidney. Proc Natl Acad Sci USA 97:1242-1246 (Pubitemid 30080843)
26. Møller N, Nair KS 2008 Diabetes and protein metabolism. Diabetes 57:3-4
27. Nair KS, Ford GC, Ekberg K, Fernqvist-Forbes E, Wahren J 1995 Protein dynamics in whole body and in splanchnic and leg tissues in type I diabetic patients. J Clin Invest 95:2926-2937
28. Nair KS, Halliday D, Garrow JS 1984 Increased energy expenditure in poorly controlled type 1 (insulin-dependent) diabetic patients. Diabetologia 27:13-16 (Pubitemid 14096661)
29. Newgard CB, An J, Bain JR, Muehlbauer MJ, Stevens RD, Lien LF, Haqq AM, Shah SH, Arlotto M, Slentz CA, Rochon J, Gallup D, Ilkayeva O, Wenner BR, Yancy Jr WS, Eisenson H, Musante G, Surwit RS, Millington DS, Butler MD, Svetkey LP 2009 A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 9:311-326
30. Nygren J, Nair KS 2003 Differential regulation of protein dynamics in splanchnic and skeletal muscle beds by insulin and amino acids in healthy human subjects. Diabetes 52:1377-1385 (Pubitemid 36666191)
31. Pereira S, Marliss EB, Morais JA, Chevalier S, Gougeon R 2008 Insulin resistance of protein metabolism in type 2 diabetes. Diabetes 57:56-63
32. Rasmussen BB, Fujita S, Wolfe RR, Mittendorfer B, Roy M, Rowe VL, Volpi E 2006 Insulin resistance of muscle protein metabolism in aging. FASEB J 20:768-769 (Pubitemid 46671209)
33. Short KR, Meek SE, Moller N, Ekberg K, Nair KS 1999 Whole body protein kinetics using Phe and Tyr tracers: an evaluation of the accuracy of approximated flux values. Am J Physiol 276:E1194-E1200 (Pubitemid 29323434)
34. Short KR, Vittone JL, Bigelow ML, Proctor DN, Nair KS 2004 Age and aerobic exercise training effects on whole body and muscle protein metabolism. Am J Physiol Endocrinol Metab 286:E92-E101 (Pubitemid 38036614)
35. Sreekumar R, Halvatsiotis P, Schimke JC, Nair KS 2002 Gene expression profile in skeletal muscle of type 2 diabetes and the effect of insulin treatment. Diabetes 51:1913-1920 (Pubitemid 34564306)
36. Staten MA, Matthews DE, Bier DM 1986 Leucine metabolism in type II diabetes mellitus. Diabetes 35:1249-1253 (Pubitemid 17186520)
37. Stump CS, Short KR, Bigelow ML, Schimke JM, Nair KS 2003 Effect of insulin on human skeletal muscle mitochondrial ATP production, protein synthesis, and mRNA transcripts. Proc Natl Acad Sci USA 100:7996-8001 (Pubitemid 36760083)
38. Suhre K, Meisinger C, Döring A, Altmaier E, Belcredi P, Gieger C, Chang D, Milburn MV, Gall WE, Weinberger KM, Mewes HW, Hrabé de Angelis M, Wichmann HE, Kronenberg F, Adamski J, Illig T 2010 Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting. PLoS One 5:e13953
39. Umpleby AM, Boroujerdi MA, Brown PM, Carson ER, Sönksen PH 1986 The effect of metabolic control on leucine metabolism in type 1 (insulin-dependent) diabetic patients. Diabetologia 29:131-141 (Pubitemid 16137020)
40. Welle S, Nair KS 1990 Failure of glyburide and insulin treatment to decrease leucine flux in obese type II diabetic patients. Int J Obes 14:701-710 (Pubitemid 20261773)